scispace - formally typeset
D

Dennis Cordato

Researcher at Liverpool Hospital

Publications -  138
Citations -  2700

Dennis Cordato is an academic researcher from Liverpool Hospital. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 25, co-authored 118 publications receiving 1956 citations. Previous affiliations of Dennis Cordato include University of Sydney & Griffith University.

Papers
More filters
Journal ArticleDOI

Post-vaccination encephalomyelitis: Literature review and illustrative case

TL;DR: A patient presenting with bilateral optic neuropathies within 3 weeks of “inactivated” influenza vaccination followed by delayed onset of ADEM 3 months post-vaccination is described.
Journal ArticleDOI

Reperfusion therapy in acute ischemic stroke: dawn of a new era?

TL;DR: Research on advanced imaging-based approaches to select appropriate patients, may widen the time-window for patient selection and would contribute immensely to early thrombolytic strategies, better recanalization rates, and improved clinical outcomes.
Journal ArticleDOI

Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK Part 2 randomized clinical trial

Bruce C.V. Campbell, +63 more
- 07 Apr 2020 - 
TL;DR: Among patients with large vessel occlusion ischemic stroke, a dose of 0.40 mg/kg of tenecteplase did not significantly improve cerebral reperfusion prior to endovascular thrombectomy, and the findings suggest that the0.40-mg/kg dose ofTenecte Plase does not confer an advantage over the 0.25-mg-kg dose.
Journal ArticleDOI

Delirium within Three Days of Stroke in a Cohort of Elderly Patients

TL;DR: To evaluate the incidence of stroke, risk factors for stroke, and outcomes in elderly stroke patients with delirium, a large number of patients withDelirium are diagnosed with stroke-like symptoms.
Journal ArticleDOI

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Graeme J. Hankey, +310 more
- 01 Aug 2020 - 
TL;DR: Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures.